Nortem Biogroup (XPAR:MLBIO) Cash-to-Debt : 0.08 (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Nortem Biogroup Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Nortem Biogroup's cash to debt ratio for the quarter that ended in Dec. 2023 was 0.08.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Nortem Biogroup couldn't pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Nortem Biogroup's Cash-to-Debt or its related term are showing as below:

XPAR:MLBIO' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.02 Med: 0.04 Max: 0.08
Current: 0.08

During the past 3 years, Nortem Biogroup's highest Cash to Debt Ratio was 0.08. The lowest was 0.02. And the median was 0.04.

XPAR:MLBIO's Cash-to-Debt is not ranked
in the Consumer Packaged Goods industry.
Industry Median: 0.5 vs XPAR:MLBIO: 0.08

Nortem Biogroup Cash-to-Debt Historical Data

The historical data trend for Nortem Biogroup's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Nortem Biogroup Cash-to-Debt Chart

Nortem Biogroup Annual Data

Trend

Dec21

Dec22

Dec23

Cash-to-Debt

0.04

0.02

0.08

Nortem Biogroup Semi-Annual Data
	Dec21	Dec22	Dec23
Cash-to-Debt	0.04	0.02	0.08

Competitive Comparison of Nortem Biogroup's Cash-to-Debt

For the Packaged Foods subindustry, Nortem Biogroup's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nortem Biogroup's Cash-to-Debt Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Nortem Biogroup's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Nortem Biogroup's Cash-to-Debt falls into.

Nortem Biogroup Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Nortem Biogroup's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0.409	/	(2.974	+	2.439)
	=	0.08

Nortem Biogroup's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0.409	/	(2.974	+	2.439)
	=	0.08

Nortem Biogroup (XPAR:MLBIO) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Nortem Biogroup Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Nortem Biogroup's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Nortem Biogroup Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nortem Biogroup (XPAR:MLBIO) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

Calle Alexander Humboldt 12B, Polígono Industrial Salinas de Poniente, El Puerto de Santa María, Cadiz, ESP, 11500

Website

https://www.nortembiogroup.com

Nortem Chem SA is engaged in the research, development, innovation and industrialization in the field of biochemistry and biotechnology, as well as the production and sale of products based on biochemical and/or biotechnological processes. It emerged as a biotechnological company in the field of the food and chemical industry, with maximum environmental awareness, concentrating its research and product development efforts on the development of environmentally friendly alternatives from renewable sources and obtaining its own microorganisms (Aspergillus Niger and Yarrowia lipolytica) with outstanding capabilities from adaptation and selection processes, avoiding the use of genetic modification technologies.

Nortem Biogroup Headlines

No Headlines